Miech and his colleagues provide a comprehensive review of the concerning rise in vaping among adolescents, focusing on both nicotine and cannabis products. The article highlights the health risks associated with vaping, including addiction, respiratory issues, and potential impacts on brain development.

DeFulio and Silverman offer an insightful review of contingency management (CM) as an evidence-based intervention for substance use disorders. CM involves providing tangible rewards, such as vouchers or prizes, contingent on demonstrating positive behaviors like abstinence or treatment adherence.

Wells and her team examine the profound impact of the COVID-19 pandemic on substance use patterns and mental health outcomes. This study resonates deeply with the experiences I've observed within our community during these challenging times.

Crews and Vetreno delve into the role of neuroinflammation in the development and persistence of substance use disorders (SUDs), offering a compelling perspective on the biological processes involved.

In "The Evolving Opioid Crisis: Fentanyl and Synthetic Opioids," Dr. Nora Volkow and Dr. Eric Wargo examine the alarming rise in overdose deaths attributed to fentanyl and other synthetic opioids, marking a new and more dangerous phase of the opioid epidemic in the United States.

Bogenschutz and his team present a groundbreaking study exploring the potential of psilocybin-assisted psychotherapy in treating alcohol use disorder (AUD). As someone who advocates for innovative approaches to addiction treatment, I found this research both promising and thought-provoking.

In this comprehensive meta-analysis, Tofighi and colleagues evaluate the effectiveness of digital health interventions (DHIs) for substance use disorders (SUDs). With the increasing integration of technology into healthcare, this article is both timely and relevant.

Agrawal and Kendler provide an in-depth exploration of the genetic factors contributing to addiction, highlighting significant advances in molecular genetics. The article offers a comprehensive overview of how genetic variations influence susceptibility to substance use disorders.